NEU 1.45% $16.33 neuren pharmaceuticals limited

a precise value for the entire content of Neuren can only be...

  1. 521 Posts.
    lightbulb Created with Sketch. 1286
    a precise value for the entire content of Neuren can only be determined in a context of negotiation between the company and the potential buyer as it depends on many factors, even of a different financial nature.the certain points on which the market will find technical answers to progress are 1.64 $, in succession 1.84 $, 3.24 $ and the first final target 4 $ per share. this is the technical scenario on which the market should capitalize on Neuren for the Trofinetide deal only. secondly or next technical scenario, the value of 2591 on which, however, the numbers are of greater weight.we live with serenity the next by virtue of the analysis of 'Friend Little T that has well certified that to date we are much better than a few years ago both from a financial and scientific point of view.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.33
Change
-0.240(1.45%)
Mkt cap ! $2.087B
Open High Low Value Volume
$16.49 $16.62 $15.60 $11.97M 733.8K

Buyers (Bids)

No. Vol. Price($)
1 403 $16.31
 

Sellers (Offers)

Price($) Vol. No.
$16.42 1763 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.